Prospective Symptom Assessment in Children with Advanced Cancer |
University of Wisconsin - Madison / Kathleen Montgomery, PhD & Jennifer Madden, RN/MSN |
Nurse Researcher Grants |
2015 |
Wisconsin |
Development of An Innovative Treatment Strategy for Neuroblastoma and Other Pediatric Tumors: A Novel Phospholipid Ester Analogue and its Multifunctional Cancer-targeting Nanoconstruct |
University of Wisconsin - Madison / Mario Otto |
Young Investigator Grants |
2012 |
Wisconsin |
Epigenetic Enhancement of MHCI to Augment Neuroblastoma Immunotherapy |
University of Wisconsin - Madison / Paul Sondel, MD, PhD and Amy Erbe-Gurel, PhD |
Innovation Grants |
2022 |
Wisconsin |
Pediatric Oncology Nurses' Experiences with Prognosis-Related Communication |
Marquette University / Amy Newman, RN, MSN |
Nurse Researcher Grants |
2014 |
Wisconsin |
Identifying how Pre-existing Anti-Therapeutic Antibodies (PATA) are Associated with Better Outcome in a Clinical Trial of ADCC-inducing Anti-GD2 mAb |
University of Wisconsin - Madison / Paul Sondel, MD, PhD |
Innovation Grants |
2015 |
Wisconsin |
Targeting EZHIP as a therapeutic strategy for infantile ependymomas |
University of Wisconsin - Madison / Peter Lewis, PhD |
Innovation Grants |
2021 |
Wisconsin |
Molecular Signature of Inflammation |
Medical College of Wisconsin / Subramaniam Malarkannan, PhD |
Springboard Grants |
2013 |
Wisconsin |
Building Capacity for the Clinical Trials Office at Children's Hospital of Wisconsin - Strengthening Phase I & II Trials Infrastructure |
Children’s Hospital of Wisconsin - Milwaukee / Michael J. Burke, MD |
Phase I/II Infrastructure Grants |
2015 |
Wisconsin |
Phase I Study of Lentivirus Engineered Autologous AML Cells Expressing IL-12 in Children and Young Adults with Relapsed AML |
Children’s Hospital of Wisconsin - Milwaukee / Michael Burke, MD & Jeffrey Medin, MD/PhD |
Reach Grants |
2017 |
Wisconsin |